Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.

Lehmann J, Enssle KH, Lehmann I, Emmendörfer A, Lohmann-Matthes ML.

J Interferon Cytokine Res. 2000 Jan;20(1):63-77.

PMID:
10670653
2.

Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases.

Jung T, Schrader N, Hellwig M, Enssle KH, Neumann C.

Int Arch Allergy Immunol. 1999 May;119(1):23-30.

PMID:
10341317
3.

Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA.

Jung T, Bews JP, Enssle KH, Wagner K, Neumann C, Heusser CH.

J Immunol Methods. 1998 Aug 1;217(1-2):41-50.

PMID:
9776573
4.

Th1 and Th2 cytokines in mice with invasive aspergillosis.

Cenci E, Perito S, Enssle KH, Mosci P, Latgé JP, Romani L, Bistoni F.

Infect Immun. 1997 Feb;65(2):564-70.

5.

CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Mencacci A, Spaccapelo R, Del Sero G, Enssle KH, Cassone A, Bistoni F, Romani L.

Infect Immun. 1996 Dec;64(12):4907-14.

6.

Differential modulation of T cell functions by soluble IL-4R (s1L-4R) in two cases of severe atopic dermatitis.

Nasert S, Millner M, Enssle KH, Wahn U, Renz H.

Pediatr Allergy Immunol. 1996 May;7(2):91-4. No abstract available.

PMID:
8902859
7.

Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R).

Schorlemmer HU, Dickneite G, Kanzy EJ, Enssle KH.

Inflamm Res. 1995 Aug;44 Suppl 2:S194-6.

PMID:
8548394
8.

Regulation of IL-1 activity by soluble IL-1 receptors.

Kurrle R, Lauffer L, Röder J, Kanzy EJ, Enssle KH, Seiler FR.

Behring Inst Mitt. 1995 Jun;(96):45-57. Review. No abstract available.

PMID:
7575352
9.

T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development.

Cenci E, Mencacci A, Spaccapelo R, Tonnetti L, Mosci P, Enssle KH, Puccetti P, Romani L, Bistoni F.

J Infect Dis. 1995 May;171(5):1279-88.

PMID:
7751704
10.

Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis.

Gessner A, Schröppel K, Will A, Enssle KH, Lauffer L, Röllinghoff M.

Infect Immun. 1994 Oct;62(10):4112-7.

11.

Cure of murine candidiasis by recombinant soluble interleukin-4 receptor.

Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Mosci P, Enssle KH, Romani L, Bistoni F.

J Infect Dis. 1994 Jun;169(6):1325-31.

PMID:
8195611
14.

Monoclonal antibodies directed to leukocyte differentiation antigens for therapeutic use.

Kurrle R, Enssle KH, Seiler FR.

Behring Inst Mitt. 1988 Apr;(82):154-73. Review.

PMID:
3044337
15.

Human mumps virus-specific cytotoxic T lymphocytes: quantitative analysis of HLA restriction.

Enssle KH, Wagner H, Fleischer B.

Hum Immunol. 1987 Feb;18(2):135-49.

PMID:
2435685

Supplemental Content

Loading ...
Support Center